Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,874.37
    -2.68 (-0.03%)
     
  • Bitcoin USD

    64,651.82
    +1,209.52 (+1.91%)
     
  • CMC Crypto 200

    1,369.79
    +57.17 (+4.56%)
     
  • S&P 500

    5,005.02
    -6.10 (-0.12%)
     
  • Dow

    37,979.55
    +204.17 (+0.54%)
     
  • Nasdaq

    15,491.87
    -109.62 (-0.70%)
     
  • Gold

    2,405.20
    +7.20 (+0.30%)
     
  • Crude Oil

    83.12
    +0.39 (+0.47%)
     
  • 10-Yr Bond

    4.6250
    -0.0220 (-0.47%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Why Johnson & Johnson Is Trashing 60 Million Doses of Its COVID Vaccine

Johnson & Johnson (NYSE: JNJ) hasn't become the major player in the COVID-19 vaccine market that many expected it to be, in large part because of manufacturing issues at a contractor's facility. Now, those issues have become even worse, and the Food and Drug Administration has told the healthcare giant that it must discard 60 million doses of its COVID-19 vaccine. In this Motley Fool Live video recorded on June 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss why J&J is having to dump these vaccine doses.